Search

Your search keyword '"Cristoferi L"' showing total 254 results

Search Constraints

Start Over You searched for: Author "Cristoferi L" Remove constraint Author: "Cristoferi L"
254 results on '"Cristoferi L"'

Search Results

1. Improving predictive accuracy in primary biliary cholangitis: A new genetic risk score

2. Adequate versus deep response to ursodeoxycholic acid in primary biliary cholangitis: To what extent and under what conditions is normal alkaline phosphatase level associated with complication-free survival gain?

3. European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care

4. OC.05.7: CHOLESTASIS IMPACTS ON PERFORMANCE OF NON INVASIVE TESTS FOR RULING OUT HIGH-RISK ESOPHAGEALVARICES IN PATIENTS WITH PRIMARY BILIARY CHOLANGITIS AND COMPENSATED ADVANCED CHRONIC LIVER DISEASE

5. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

6. Liver Transplantation for Primary Sclerosing Cholangitis (PSC) With or Without Inflammatory Bowel Disease (IBD)—A European Society of Organ Transplantation (ESOT) Consensus Statement

7. Predictors of serious adverse events and non-response in cirrhotic patients with primary biliary cholangitis treated with obeticholic acid

8. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

9. The Role of Epigenetics in Primary Biliary Cholangitis

10. X marks the spot in autoimmunity

11. SARS-CoV-2 vaccination and risk of severe COVID-19 outcomes in patients with autoimmune hepatitis

12. Role of ductular reaction and ductular–canalicular junctions in identifying severe primary biliary cholangitis

13. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

16. RADIOLOGY-BASED BIOMARKERS DISCOVERY IN PRIMARY SCLEROSING CHOLANGITIS: FROM RISK STRATIFICATION TO THE EVALUATION OF TREATMENT BENEFIT

17. Endocrinology and Metabolic Diseases (Including Diabetes)

19. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

20. Risk stratification in primary sclerosing cholangitis

22. A quantitative MRCP-derived score for medium-term outcome prediction in primary sclerosing cholangitis

23. Corrigendum to ‘An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs’ [J Hepatol 2021;75(3):572–581] (Journal of Hepatology (2021) 75(3) (572–581), (S0168827821003342), (10.1016/j.jhep.2021.04.055))

24. Elastography in Autoimmune Liver Diseases

25. Real-world experience with obeticholic acid in patients with primary biliary cholangitis

26. Takayasu arteritis and primary sclerosing cholangitis: A casual association or different phenotypes of the same disease?

27. X Chromosome Contribution to the Genetic Architecture of Primary Biliary Cholangitis

28. An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs

29. Outcome of COVID-19 in Patients With Autoimmune Hepatitis: An International Multicenter Study

32. Multiple therapeutic targets in rare cholestatic liver diseases: Time to redefine treatment strategies

34. Individualizing Care: Management Beyond Medical Therapy

35. COVID-19 in Patients With Inflammatory Bowel Disease: A Single-center Observational Study in Northern Italy

36. Glycomic analysis of antibody indicates distinctive glycosylation profile in patients with autoimmune cholangitis

37. Primary sclerosing cholangitis: Burden of disease and mortality using data from the national rare diseases registry in Italy

38. New Therapeutic Targets in Autoimmune Cholangiopathies

39. Accuracy of Liver Stiffness Measurement in assessing liver fibrosis in naïve patients with Primary Biliary Cholangitis

40. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

41. LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis

42. Systematic review-Pancreatic involvement in inflammatory bowel disease

43. Liver stiffness measurement by vibration-controlled transient elastography improves outcome prediction in primary biliary cholangitis

44. Clinical treatment of cholangiocarcinoma: an updated comprehensive review

45. An update on novel pharmacological agents for primary sclerosing cholangitis

46. Artificial intelligence for precision medicine in autoimmune liver disease

47. Effects of immunosuppressive drugs on COVID-19 severity in patients with autoimmune hepatitis

48. Machine learning in primary biliary cholangitis: A novel approach for risk stratification

49. PC.01.8 RADIOMICS-BASED MODEL FOR OUTCOME PREDICTION IN PRIMARY SCLEROSING CHOLANGITIS

50. Radiomics-based model for outcome prediction in primary sclerosing cholangitis

Catalog

Books, media, physical & digital resources